Navigation Links
HRT Users Who Get Breast Cancer Less Likely to Die

They tend to get type of tumors that have better prognosis, study finds

FRIDAY, Dec. 12 (HealthDay News) -- Taking hormone therapy after menopause is known to increase the risk of getting breast cancer, but women who take hormone therapy and then develop breast cancer have a lower risk of dying from the disease, a new study suggests.


"Hormone therapy seems to give you a particular type of cancer that is easier to treat," explained study author Sarah F. Marshall, a senior statistician at the University of California Irvine. She is to report her finding on Saturday at the San Antonio Breast Cancer Symposium, in Texas.

"We found that women who took hormone therapy before their diagnosis were more likely to be diagnosed with estrogen receptor-positive cancer, as well as having breast cancers that were more favorable in other ways, [such as being] smaller and detected at an earlier stage," Marshall said.

Estrogen-receptor positive breast cancers depend on estrogen to grow. Giving anti-estrogen therapy (such as tamoxifen) treats the cancer.

Marshall and her colleagues evaluated almost 2,800 postmenopausal women who were diagnosed with a primary invasive breast cancer after joining the study in 1995 and 1996. The researchers then tracked outcomes through the end of 2005, or until the women's death.

"We looked at self-reported use of hormone therapy before their diagnosis," Marshall said. "We compared three groups -- those without [current or previous hormone use], those on estrogen alone, and those on estrogen-progestin."

Those taking estrogen-progestin had a 47 percent reduced risk of death from breast cancer during the follow-up compared to those who did not take hormone therapy. Those on estrogen alone had an 18 percent reduced risk of breast cancer death, but that was not statistically significant, she said.

The study results may be somewhat reassuring for women who took hormone replacement therapy, she said.

The finding is not surprising, said Dr. Victor G. Vogel, the incoming national vice president of research for the American Cancer Society and a professor of medicine and epidemiology at the University of Pittsburgh. "It says if you are taking HRT, your risk of getting breast cancer is higher, but your risk of dying from breast cancer is less," he said.

The finding may be surprising, he added, to those who don't appreciate the complex interaction between estrogen and breast cancer, which is still something of a paradox, he said.

In other presentations at the conference, researchers reported that:

  • Estrogen therapy may help women with metastatic breast cancer whose tumors stopped responding to anti-estrogen therapy. Giving the estrogen may return metastatic tumors to a vulnerable state after which patients can then be cycled back to the anti-estrogen therapy. The concept is not new, Vogel noted.
  • A switch to the drug anastrazole after one to four years of tamoxifen boosts disease-free survival by about 31 percent, according to another study, but patients report worse quality of life. But quality-of-life issues can generally be treated and improved, Vogel said.
  • The drug letrozole may beat out tamoxifen in improving overall survival in patients with primary breast cancer. A comparison study of the two found that letrozole reduces breast cancer recurrence and may decrease the risk of breast cancer death by 13 percent.

More information

To learn more about breast cancer, visit the American Cancer Society.

SOURCES: Victor G. Vogel, M.D., M.H.S., incoming national vice president, research, American Cancer Society, and professor, medicine and epidemiology, University of Pittsburgh; Sarah F. Marshall, senior statistician, University of California, Irvine; Dec. 12, 2008, presentation, San Antonio Breast Cancer Symposium, Texas

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. HCV and HBV spreading more slowly among injection drug users in San Francisco
2. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
3. Slowed Brain-Activity in Frequent Mobile Phone Users
4. Genes Might Predispose Antidepressant Users to Suicidal Thoughts
5. Defib Wire Warning Shouldnt Worry Most Users: Experts
6. National Magazine Ranks Highmark 62nd Among Nations 500 Most Innovative Users of Information Technology
7. IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users
8. National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High-Tech World
9. Former substance abusers rarely relapse after organ transplantation
10. One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project
11. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
Post Your Comments:
Related Image:
HRT Users Who Get Breast Cancer Less Likely to Die
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... online platform for mental health and wellness consultation, has collaborated with a leading ... bridge the knowledge gap experienced by parents and bring advice from parenting experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: